ALGN
Price
$138.59
Change
-$1.29 (-0.92%)
Updated
Aug 11, 11:36 AM (EDT)
Capitalization
10.14B
79 days until earnings call
CNVVY
Price
$12.50
Change
+$0.01 (+0.08%)
Updated
Aug 8 closing price
Capitalization
6.3B
Interact to see
Advertisement

ALGN vs CNVVY

Header iconALGN vs CNVVY Comparison
Open Charts ALGN vs CNVVYBanner chart's image
Align Technology
Price$138.59
Change-$1.29 (-0.92%)
Volume$8.57K
Capitalization10.14B
ConvaTec Group
Price$12.50
Change+$0.01 (+0.08%)
Volume$12.24K
Capitalization6.3B
ALGN vs CNVVY Comparison Chart in %
Loading...
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNVVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGN vs. CNVVY commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Hold and CNVVY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (ALGN: $139.88 vs. CNVVY: $12.50)
Brand notoriety: ALGN: Notable vs. CNVVY: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALGN: 126% vs. CNVVY: 16%
Market capitalization -- ALGN: $10.14B vs. CNVVY: $6.3B
ALGN [@Pharmaceuticals: Other] is valued at $10.14B. CNVVY’s [@Pharmaceuticals: Other] market capitalization is $6.3B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $168.51B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 0 FA rating(s) are green whileCNVVY’s FA Score has 1 green FA rating(s).

  • ALGN’s FA Score: 0 green, 5 red.
  • CNVVY’s FA Score: 1 green, 4 red.
According to our system of comparison, CNVVY is a better buy in the long-term than ALGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 5 TA indicator(s) are bullish while CNVVY’s TA Score has 4 bullish TA indicator(s).

  • ALGN’s TA Score: 5 bullish, 5 bearish.
  • CNVVY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ALGN and CNVVY are a good buy in the short-term.

Price Growth

ALGN (@Pharmaceuticals: Other) experienced а +2.46% price change this week, while CNVVY (@Pharmaceuticals: Other) price change was +0.73% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.86%. For the same industry, the average monthly price growth was -3.35%, and the average quarterly price growth was +2.88%.

Reported Earning Dates

ALGN is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+1.86% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALGN($10.1B) has a higher market cap than CNVVY($6.3B). CNVVY has higher P/E ratio than ALGN: CNVVY (29.48) vs ALGN (23.63). CNVVY YTD gains are higher at: 10.781 vs. ALGN (-32.914). ALGN has higher annual earnings (EBITDA): 804M vs. CNVVY (567M). ALGN has more cash in the bank: 873M vs. CNVVY (95.7M). ALGN has less debt than CNVVY: ALGN (119M) vs CNVVY (1.34B). ALGN has higher revenues than CNVVY: ALGN (3.98B) vs CNVVY (2.36B).
ALGNCNVVYALGN / CNVVY
Capitalization10.1B6.3B160%
EBITDA804M567M142%
Gain YTD-32.91410.781-305%
P/E Ratio23.6329.4880%
Revenue3.98B2.36B169%
Total Cash873M95.7M912%
Total Debt119M1.34B9%
FUNDAMENTALS RATINGS
ALGN vs CNVVY: Fundamental Ratings
ALGN
CNVVY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
24
Undervalued
PROFIT vs RISK RATING
1..100
10054
SMR RATING
1..100
6685
PRICE GROWTH RATING
1..100
6562
P/E GROWTH RATING
1..100
8983
SEASONALITY SCORE
1..100
4565

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNVVY's Valuation (24) in the null industry is somewhat better than the same rating for ALGN (77) in the Medical Specialties industry. This means that CNVVY’s stock grew somewhat faster than ALGN’s over the last 12 months.

CNVVY's Profit vs Risk Rating (54) in the null industry is somewhat better than the same rating for ALGN (100) in the Medical Specialties industry. This means that CNVVY’s stock grew somewhat faster than ALGN’s over the last 12 months.

ALGN's SMR Rating (66) in the Medical Specialties industry is in the same range as CNVVY (85) in the null industry. This means that ALGN’s stock grew similarly to CNVVY’s over the last 12 months.

CNVVY's Price Growth Rating (62) in the null industry is in the same range as ALGN (65) in the Medical Specialties industry. This means that CNVVY’s stock grew similarly to ALGN’s over the last 12 months.

CNVVY's P/E Growth Rating (83) in the null industry is in the same range as ALGN (89) in the Medical Specialties industry. This means that CNVVY’s stock grew similarly to ALGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNCNVVY
RSI
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 4 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
62%
Momentum
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
55%
MACD
ODDS (%)
Bearish Trend 4 days ago
69%
Bullish Trend 4 days ago
47%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
53%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
61%
Declines
ODDS (%)
Bearish Trend 12 days ago
70%
Bearish Trend 6 days ago
55%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
70%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNVVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CRTC34.990.10
+0.29%
Xtrackers US National Crtcl Techs ETF
STPZ53.97N/A
N/A
PIMCO 1-5 Year US TIPS Index ETF
CCSB20.47N/A
N/A
Carbon Collective Short Dur Grn Bd ETF
TFI44.55-0.02
-0.04%
SPDR Nuveen ICE Municipal Bond ETF
ERY22.79-0.26
-1.13%
Direxion Daily Energy Bear 2X ETF

ALGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGN has been loosely correlated with JNDOF. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGN jumps, then JNDOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGN
1D Price
Change %
ALGN100%
+2.18%
JNDOF - ALGN
60%
Loosely correlated
N/A
BAX - ALGN
59%
Loosely correlated
N/A
LUNG - ALGN
54%
Loosely correlated
-4.32%
NVST - ALGN
44%
Loosely correlated
+0.75%
ITGR - ALGN
44%
Loosely correlated
+0.69%
More

CNVVY and

Correlation & Price change

A.I.dvisor tells us that CNVVY and ALGN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNVVY and ALGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNVVY
1D Price
Change %
CNVVY100%
+0.08%
ALGN - CNVVY
27%
Poorly correlated
+2.18%
SGHT - CNVVY
25%
Poorly correlated
+19.44%
RVTY - CNVVY
24%
Poorly correlated
+0.44%
KIDS - CNVVY
22%
Poorly correlated
-1.51%
CRL - CNVVY
21%
Poorly correlated
-0.69%
More